Michael Popp

CEO & Vice-Chair of the Board of Directors, Bionorica Se

Search every verified Michael Popp interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. In a 2019 interview, Michael Popp, CEO and Vice-Chair of the Board of Directors at Bionorica SE, discussed his early entry into the company as a young third-generation owner, describing it as a leap into cold water. He noted that a major initial challenge was the need to secure the company's business model by obtaining new drug approvals for its products, as the European pharmaceutical market was being reassessed following the "contact affair." Popp stated that he chose to pursue new approvals rather than re-registrations on the recommendation of the regulatory authority. Popp also commented on the role of nature in pharmaceutical innovation, asserting that nearly 70 percent of innovations in pharmacy originate from nature, either in their original form or modified, including treatments for cancer and malaria. He emphasized the importance of maintaining an intact environment for human survival and quality of life, stating that people and their plants thrive only in a healthy environment.